Systemic Conditions Affecting the Feet

Haemochromatosis

Systemic Conditions Affecting the Feet· Also known as: hemochromatosis, iron overload disorder, bronze diabetesUpdated Nov 2026

Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod, November 2026

At a Glance

Haemochromatosis is an inherited condition in which your body takes in more iron from food than it needs and cannot get rid of the extra. Over many years the iron builds up in organs such as the liver, heart and pancreas, and in the joints. It affects roughly 1 in 220 to 250 people of northern European descent, though carrying the gene change does not guarantee illness. Early symptoms are vague, such as tiredness and joint pain, and many people have none. Finding it early helps prevent serious problems.

What is it?

Haemochromatosis is a group of inherited conditions (passed down through families in your genes) in which iron collects in the body, mainly in the liver. Over time this can change how those organs are built and how well they work.

The main problem is that your body absorbs more iron from food than it needs, and it has no way of removing the extra. The surplus is stored in organs and joints, including the liver, heart, pancreas and joints, and it builds up slowly over many years.

Left untreated, it can lead to serious problems such as scarring of the liver (cirrhosis), liver cancer, diabetes and heart disease. This is why finding it early matters.

You may also see it called hereditary haemochromatosis or iron overload disorder.

Who does it affect?

Haemochromatosis is the most common genetic condition in people of northern European descent. It occurs in about 1 in 220 to 250 people. Other estimates are a little higher, from about 1 in 150 to 1 in 225.

It is uncommon in China and other parts of Asia. Nearly all cases there come from changes in genes other than the one that is usual in Europe.

Having the gene changes does not mean you will become ill. Illness linked to iron overload is more common in men than in women, and it becomes more common with age.

Brothers, sisters and children of a person with haemochromatosis are the people screening is advised for, because they have a higher chance of carrying the same gene changes.

Signs and symptoms

Early symptoms are vague. They include tiredness, weakness, weight loss and joint pain, and some people have erectile dysfunction. They usually start between the ages of 30 and 60, and often closer to 50 in women.

Many people have no symptoms at all. Up to 18 per cent of men and 5 per cent of women may have extra iron in the liver without feeling unwell. Because symptoms creep up slowly, the condition is often found late, when organs may already be damaged.

Joint pain is often the first sign. The joint disease looks like osteoarthritis (wear in the joints) but appears at a younger age. It typically affects the knuckles at the base of the index and middle fingers (the 2nd and 3rd metacarpophalangeal joints) and the ankles. It can also involve the hips, knees, wrists, shoulders and elbows. The finger pattern is sometimes called the "painful handshake" sign.

Because of this, joint symptoms can be mistaken for rheumatoid arthritis (an inflammatory arthritis), for faster-than-usual osteoarthritis, or for calcium pyrophosphate deposition (CPPD, a joint problem caused by crystals). Haemochromatosis is a recognised risk factor for CPPD.

Some signs point to a more serious problem from iron overload. Cirrhosis, the severe scarring of the liver, can bring on tiredness, weakness, reduced appetite, weight loss, nausea, intensely itchy skin, pain or tenderness in the liver area, and yellow eyes and skin (jaundice).

When the heart is affected (heart failure), signs include shortness of breath, extreme tiredness and weakness, and swelling in the legs, ankles and feet. Heart failure can usually be treated with medicine.

Rarely, iron in the brain causes movement problems such as tremor, jerky movements (chorea) or parkinsonism (stiffness and slowness). High iron can also weaken the immune system, which raises the risk of infection with certain bacteria.

What causes it?

Haemochromatosis is caused by a faulty gene that changes how your body absorbs iron from your diet. The gene most often involved is called HFE, and the usual change in it is called C282Y.

The condition is recessive. This means it arises when you inherit a copy of the faulty gene from each parent. About 85 to 90 per cent of people with inherited iron overload have two copies of C282Y. A small number have two different changes (C282Y and H63D), which seldom causes significant iron overload on its own. In those people, alcohol or metabolic syndrome may contribute more to a high iron reading than the gene change does.

If you have just one copy, you do not get haemochromatosis, but you can pass the gene on to your children. Only some people with two copies become ill, and the reason isn't known.

How is it diagnosed?

It usually starts with blood tests. Transferrin saturation (how full your iron carriers are) is the preferred first test, and you do not need to fast for it. Ferritin (a measure of your iron stores) is checked too.

In one approach, no further work-up is needed if transferrin saturation is below 45 per cent and ferritin is normal. If saturation is 45 per cent or above and ferritin is raised, a gene test for HFE follows. There is no single cut-off that every guideline uses.

A clinical diagnosis requires both two copies of C282Y and blood evidence of iron overload.

Ferritin can be raised for other reasons, such as alcohol, weight gain, a sedentary lifestyle, or inflammatory or liver disease. So a high ferritin does not on its own mean haemochromatosis, and results are read alongside transferrin saturation.

A ferritin above 1000 µg/L, or raised liver enzymes, can signal liver scarring. Among people with two C282Y copies and ferritin above 1000 µg/L, 20 to 45 per cent have cirrhosis. Below that level it is under 2 per cent, unless another risk factor is present, such as heavy alcohol use, viral hepatitis or fatty liver. In these cases a liver specialist may assess the liver for scarring.

For close relatives of someone with haemochromatosis, screening uses iron blood tests and an HFE gene test, ideally done together at one visit.

Treatment

Looking after it at home

These are the everyday measures usually described for people with high iron levels:

  • Avoiding iron and vitamin C supplements, and iron-fortified breakfast cereals. This is advised for people having blood removal (phlebotomy, also called venesection), and while haemochromatosis is being investigated.
  • Not cutting out all iron-containing foods. Dietary iron does not need to be restricted. Avoiding it is unlikely to add much to treatment and could mean missing needed nutrition.
  • Limiting alcohol, to help prevent liver damage. One service gives 14 units or less per week. Alcohol is stopped completely if cirrhosis is present.
  • Avoiding raw or undercooked shellfish such as oysters, mussels and clams. Bacteria in them can cause serious or even fatal infections in people with high iron levels.

Some dietary, herbal and complementary products contain high levels of iron or unsafe ingredients. A doctor may also suggest vaccination against hepatitis A and hepatitis B.

Other options

Joint damage from haemochromatosis behaves differently from the iron levels. It is unrelated to ferritin readings and seldom improves with venesection and iron depletion. It isn't yet clear which other treatments work best for the joints.

Surgery

Joint disease from haemochromatosis can be difficult to treat, and it carries a high risk of early joint replacement.

Recovery

The outlook varies from person to person. Not everyone with two C282Y copies becomes ill. Fewer than 10 per cent develop fully expressed disease with organ damage. Another group found documented iron-related disease in 28.4 per cent of men and 1.2 per cent of women with two copies. The figures differ with how disease is defined.

Illness is more common in men but also occurs in women, and it becomes more common with age.

Joint disease is often the earliest sign and is difficult to treat. Finding haemochromatosis early helps prevent illness and death.

Preventing it

You cannot change the genes you inherit, but finding haemochromatosis early helps prevent illness. Genetic testing can show whether someone in a family carries the gene.

Screening is advised for brothers, sisters and children of a person with haemochromatosis. Testing adult children of people with two C282Y copies is recommended because their chance of having the same gene change, and related illness, is higher.

When someone is diagnosed, their brothers, sisters and adult children can then ask about testing, so that treatment and preventive steps can start promptly.

Frequently asked questions

When are children of someone with haemochromatosis tested?

The usual step is to test the child's other parent for the HFE gene change. If that parent can't be tested, testing of the child can wait until age 18, because clinical disease seldom shows up before then.

Can haemochromatosis cause liver cancer?

Cirrhosis (scarring of the liver) raises the chance of liver cancer. When cirrhosis is present, blood tests and an ultrasound or another type of imaging may be suggested to check for liver cancer.

Can the gene change be found before symptoms start?

Yes. Blood signs of iron overload usually appear before symptoms, with a raised transferrin saturation the first indicator. Genetic testing can also show whether you carry the gene, including when a family member has haemochromatosis.

Further reading

This is general information, not medical advice. For advice about your own situation, see your health professional. For urgent advice, call your local health advice line or emergency number, or go to an emergency department.